A detailed history of Beaton Management Co. Inc. transactions in Amgen Inc stock. As of the latest transaction made, Beaton Management Co. Inc. holds 3,486 shares of AMGN stock, worth $915,597. This represents 0.57% of its overall portfolio holdings.

Number of Shares
3,486
Previous 3,486 -0.0%
Holding current value
$915,597
Previous $1.09 Million 3.12%
% of portfolio
0.57%
Previous 0.59%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $6,043 - $7,344
23 Added 0.66%
3,486 $1.09 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $58,613 - $70,754
218 Added 6.72%
3,463 $985,000
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $12,785 - $14,422
-50 Reduced 1.52%
3,245 $935,000
Q2 2023

Jul 21, 2023

BUY
$214.27 - $253.37 $13,927 - $16,469
65 Added 2.01%
3,295 $732,000
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $83,529 - $95,592
-420 Reduced 11.51%
3,230 $727,000
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $11,679 - $12,957
-50 Reduced 1.35%
3,650 $890,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $44,382 - $51,720
-200 Reduced 5.13%
3,700 $921,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $51,857 - $57,669
-221 Reduced 5.36%
3,900 $991,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $29,671 - $36,411
-150 Reduced 3.51%
4,121 $972,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $18,224 - $24,170
-100 Reduced 2.29%
4,271 $866,000
Q3 2019

Nov 15, 2019

BUY
$174.11 - $208.62 $8,705 - $10,431
50 Added 1.16%
4,371 $846,000
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $16,605 - $18,651
-100 Reduced 2.26%
4,321 $798,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $3,388 - $3,960
-20 Reduced 0.45%
4,421 $754,000
Q3 2017

Nov 09, 2017

SELL
$167.29 - $191.0 $16,729 - $19,100
-100 Reduced 2.2%
4,441 $828,000
Q2 2017

Aug 17, 2017

BUY
N/A
4,541
4,541 $782,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Beaton Management Co. Inc. Portfolio

Follow Beaton Management Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.